Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Cetin, Bulent; Kaplan, Mehmet; Berk, Veli; Tufan, Gulnihal; Benekli, Mustafa; Isikdogan, Abdurrahman; ÖZKAN, METİN; Coskun, UĞUR; Buyukberber, Suleyman

doi:10.1093/jjco/hys175

Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Cetin B., Kaplan M. A., Berk V., Tufan G., Benekli M., Isikdogan A., ...Daha Fazla

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.43, sa.1, ss.28-32, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 43 Sayı: 1
Basım Tarihi: 2013
Doi Numarası: 10.1093/jjco/hys175
Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.28-32
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Gazi Üniversitesi Adresli: Evet

Özet

Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns and controversies remain over combining cytotoxic chemotherapy with bevacizumab in this patient population.